{"id":"W4408338425","doi":"10.1111/1346-8138.17685","title":"Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 <scp>POETYK PSO</scp> ‐1, <scp>PSO</scp> ‐4, and <scp>LTE</scp> trials","year":2025,"lang":"en","type":"article","venue":"The Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Adverse effect; Placebo; Clinical trial; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Incidence (geometry); Dermatology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002716367,0.0005324824,0.001746233,0.0006923053,0.0002487374,0.00005137766,0.0007677691,0.0007383554,0.00001065309],"category_scores_gemma":[0.004399453,0.0003511866,0.0002362884,0.0007631961,0.0005291349,0.000301885,0.0002055013,0.001070481,0.00003703393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009403208,"about_ca_system_score_gemma":0.0002236266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002070621,"about_ca_topic_score_gemma":0.0003989206,"domain_scores_codex":[0.9914694,0.005032267,0.002035844,0.0004290341,0.0001538416,0.0008795973],"domain_scores_gemma":[0.9833696,0.01495517,0.001019358,0.0004713011,0.0001191496,0.00006538525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005439688,0.01242661,0.5476132,0.000596705,0.006097859,0.003480323,0.2741171,0.0002007395,0.02150279,0.004838312,0.0697609,0.05392574],"study_design_scores_gemma":[0.1354478,0.001799149,0.6679168,0.0009912488,0.002133955,0.008480445,0.04891005,0.00002911155,0.02025738,0.005185019,0.108557,0.0002921224],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805208,0.01552108,0.00002581543,0.0007131327,0.00102074,0.0009162402,0.00007974143,0.00002142299,0.001181026],"genre_scores_gemma":[0.9893399,0.009395655,0.00006702058,0.000677083,0.00007701844,0.00003532543,0.00006007578,0.00003267626,0.0003152727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2252071,"threshold_uncertainty_score":0.999894,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02221781675743524,"score_gpt":0.2900349899425235,"score_spread":0.2678171731850883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}